Evidence Synthesis
Vimtalabs Sees Significant Improvement in Gross Margin, with the metric 75.17% accelerating to a new high, up from 22.7%.
This improvement is a notable shift from the previous quarter.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 23 Aug 2026, 02:45
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Vimtalabs Sees Significant Improvement in Gross Margin, with the metric 75.17% accelerating to a new high, up from 22.7%.
This improvement is a notable shift from the previous quarter.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 75.17 % | 22.7 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 22.7 % | 18.91 | ▲ |
| REVENUE_GROWTH_YOY | 11.8 % | 10.7 | ▲ |
| PRICE_CHANGE_PERCENT | -1.679 % | — | - |
| DAILY_VOLUME | 90,619 shares | 4,46,060 | ▼ |
| CLOSE_PRICE | 629.65 INR | 640.4 | ▼ |